Pazopanib
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Aurobindo Pharma Limited
pazopanib hydrochloride
Listed by Novartis Pharmaceuticals Corporation
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 0078-1077 |
| FDA application | NDA022465 |
| RxNorm concept | 867502 |
| Package sizes listed | 1 |
| Marketed since | July 2016 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Aurobindo Pharma Limited
AvKARE
SUN PHARMACEUTICAL INDUSTRIES, INC.
Teva Pharmaceuticals, Inc.
pazopanib hydrochloride
Torrent Pharmaceuticals Limited
pazopanib hydrochloride
Novugen Pharma (USA) LLC.
Golden State Medical Supply, Inc.
Apotex Corp.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.